Therapeutic Expertise

Cardiovascular

Cardiovascular CRO for Clinical Trails

Cardiovascular diseases remain the leading causes of morbidity and mortality both in China and worldwide. It is estimated that about 3.5 million people in China die of cardiovascular diseases every year, ranking the first among all diseases. The safe and effective treatment and devices are still highly demanded.

For cardiovascular clinical research, patient-focused clinical operation experts, extensive domestic and global clinical trial experience and good cooperation with experts in the cardiovascular field are highlighted by clients for selecting Tigermed as their partner of choice.

Besides these criteria, the wide range of hospitals and patient centers to cooperate with are what sets Tigermed apart from other CROs. Also we have a specific focus on indications of hypertension and hyperlipidemia.

  • Broad network of certified cardiologists and investigators with strong backgrounds in academy and pharmaceutical development
  • Clinical and regulatory service integration on cardiovascular drugs and medical devices
  • Extensive experience in cardiovascular clinical trials and research in Hypertension and Heart failure, including 20+ phase II-III trials, 10+ Phase IV and real world studies

260+

Cardiovascular Clinical Trials

Key Indications

  • Hypertension
  • Hyperlipidemia
  • Chronic heart failure
  • Arrhythmias (ventricular premature beats, atrial fibrillation, etc.)
  • Coronary heart disease (acute coronary syndrome, stable angina, etc.)
  • Venous Thromboembolism
  • Variety
  • Value-based price

Let's Connect for a Conversation